Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ViiV Healthcare
With
GlaxoSmithKline
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and non-pregnant women, at least 18 years of age
Antiretroviral treatment-experienced, defined as having documented evidence of having failed 1 or 2 regimens that include 2 or 3 classes of antiretroviral (ARV) (with or without documented resistance)
CD4+ T-cell count \> 50 cells/mm3
Screening genotype/phenotype indicating susceptibility to study drugs (unboosted ATV, FC \< 2.2; DTG; TDF)
You may not be if
Antiretroviral treatment-experienced adults who have failed \> 2 ARV regimens
Resistance or partial resistance to any study drug determined by tests at Screening
Historical or documented genotypic and/or phenotypic drug resistance testing showing certain resistance mutations to ATV, TDF, RAL, Protease Inhibitors, and certain TAMs
Chronic hepatitis B virus (HBV)/ hepatitis C virus (HCV)
